SU1268170A1 - Antirheumatoid agent "pyrimidant" - Google Patents
Antirheumatoid agent "pyrimidant"Info
- Publication number
- SU1268170A1 SU1268170A1 SU741984456A SU1984456A SU1268170A1 SU 1268170 A1 SU1268170 A1 SU 1268170A1 SU 741984456 A SU741984456 A SU 741984456A SU 1984456 A SU1984456 A SU 1984456A SU 1268170 A1 SU1268170 A1 SU 1268170A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- pyrimidant
- antirheumatoid
- agent
- antirheumatoid agent
- drug
- Prior art date
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Применение 2'-Application 2'-
Description
(Л С(Ls
12681702 12681702
Изобретение относитс к медицине соли препарата раствор ютс в водеThe invention relates to medicine. Salts of the drug are dissolved in water.
и может быть использовано в качестведо 3%.and can be used as 3%.
антиревнатического средства.antirheumatic drug
Цель изобретени повышение анти Пиримидант назначают пероральревматической активности.s но из расчета 1 тйблетка (0,5 rjThe purpose of the invention is that an increase in anti-pyrimidant is prescribed for perrheumatic activity.
Антиревматическое средство Пири-4 раза в сутки. Суточиую дозу приAnti-rheumatic drug Piri-4 times a day. Total dose when
мидант представл ет собой кристал-необходимости можно увеличить доthe midant is a crystal of necessity can be increased to
лическое вещество светло елтого5,0-,0 г. Kjrpc лечени в зависимоцвета с молекул рной массой 332, ппа-сти от т жести патологического провитс при 280-28ГС с разложением,Ю цесса рекомендуетс проводить отThe light yellow substance is 5,0-, 0 g. Kjrpc treatment depends on the color with a molecular weight of 332, it is recommended to carry out the severity of the disease from 280-28 ° C with decomposition.
нерастворимым в воде, растворим в20 до 30 сут. при необходимости егоinsoluble in water, soluble in 20 to 30 days. if necessary it
ДМСО, ДМФА, в растворах щелочей иможно продлить до двух и больше меDMSO, DMF, in alkali solutions and can be extended to two or more
соды, натриева и этаноламмониева с цев.soda, sodium and ethanolamine with ce.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU741984456A SU1268170A1 (en) | 1974-01-04 | 1974-01-04 | Antirheumatoid agent "pyrimidant" |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU741984456A SU1268170A1 (en) | 1974-01-04 | 1974-01-04 | Antirheumatoid agent "pyrimidant" |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU1268170A1 true SU1268170A1 (en) | 1986-11-07 |
Family
ID=20572129
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU741984456A SU1268170A1 (en) | 1974-01-04 | 1974-01-04 | Antirheumatoid agent "pyrimidant" |
Country Status (1)
| Country | Link |
|---|---|
| SU (1) | SU1268170A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7855214B2 (en) * | 2004-01-26 | 2010-12-21 | Vertex Pharmaceuticals Incorporated | Fused cyclic systems useful as inhibitors of TEC family protein kinases |
-
1974
- 1974-01-04 SU SU741984456A patent/SU1268170A1/en active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7855214B2 (en) * | 2004-01-26 | 2010-12-21 | Vertex Pharmaceuticals Incorporated | Fused cyclic systems useful as inhibitors of TEC family protein kinases |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2038691T3 (en) | PROCEDURE FOR THE PREPARATION OF A MEDICATION FOR THE TREATMENT OF INFLAMMATIONS IN THE EYE. | |
| SE8402551L (en) | CINNAMOYLMORANOLIN DERIVATIVES | |
| KR890011823A (en) | Benzoyl phenylacetic acid derivative pharmaceutical composition | |
| ES2182108T3 (en) | TIENOTRIAZOLODIAZEPINA COMPOUNDS AND MEDICINAL USES OF THE SAME. | |
| IE41374L (en) | Composition for treating schizophrenia | |
| FR2392971A1 (en) | PROSTANOIC ACID DERIVATIVES, THEIR PREPARATION AND MEDICINAL PRODUCT CONTAINING SUCH SUBSTANCES | |
| FR2361901A1 (en) | NUCLEOTIDES SUBSTITUTION DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING THESE SUBSTANCES | |
| GB1459571A (en) | Thiophene-2-sulphonamide derivatives and their use as therapeutic agents sheet orienting apparatus | |
| SE8400332L (en) | ASSOCIATION FOR USE AS INTERMEDIATE IN THE PRODUCTION OF MEDICINAL PRODUCTS | |
| FR2390448A1 (en) | AZIDO DERIVATIVES OF PENICILLANIC ACID USEFUL IN THE PREPARATION OF MEDICINAL PRODUCTS | |
| SU1268170A1 (en) | Antirheumatoid agent "pyrimidant" | |
| DK429480A (en) | PHOSPHONO HYDROXYDIC ACETIC ACID PROCEDURES FOR PREPARING IT AND USING IT AS A MEDICINE | |
| FR2387221A1 (en) | BENZIMIDAZOLE DERIVATIVES FOR USE AS ACTIVE SUBSTANCES IN VETERINARY MEDICINAL PRODUCTS | |
| FR2230376A1 (en) | Stable solutions of siloxanic polysilanols - prepd. by hydrolysis of a silane and having pharmaceutical activity | |
| GB1168391A (en) | Substituted Uracils | |
| FR2392022A1 (en) | PROCESS FOR THE PREPARATION OF A WATER SOLUBLE COMPLEX OF 2- (4'-THIAZOLYL) BENZIMIDAZOLE AND FOR THE PREPARATION OF ANTHELMINTIC AND FUNGICIDE COMPOSITIONS | |
| FR2401141A1 (en) | NEW HALOGEN DERIVATIVES OF PROSTAGLANDINS AND MEDICINES CONTAINING THEM | |
| EP0030023A3 (en) | A heterocyclic compound and its synthesis, pharmaceutical formulations thereof and the use of the compounds and the formulations in medicine | |
| GB1374294A (en) | 2-amino-methylphenols | |
| US2715622A (en) | Anthelmintic dye salts | |
| FR2252103A1 (en) | Hydroxamino-substd. oxazolobenzodiazepines - sedatives, muscle relaxants and anti-convulsants | |
| Robertson et al. | Potassium bromate poisoning: Report of a case | |
| ES421854A1 (en) | Lysino-calcium chloride and pharmaceutically acceptable acid salts thereof | |
| SU263807A1 (en) | Medicinal preparation | |
| ATE2429T1 (en) | 6-IMIDAZOLE-1-YL-3-HYDRAZINO-PYRIDAZINE, PROCESS FOR THEIR PREPARATION AND MEDICATIONS CONTAINING THEM. |